Oxitope Pharma launched in the Netherlands

Thursday 16 September 2021
Country

Netherlands

A new Dutch biotech company was launched on 16 September to discover and develop antibody-based drugs for diseases caused by oxidative stress. Oxitope Pharma BV was founded and seed funded by Forbion Capital Partners and uses technology in-licensed from the University of California San Diego, US.